Download Paper
Khaled Hassan Alzahabi is a PhD candidate in the department of National Heart and Lung Institute at Imperial College London. His doctoral research develops a new therapy to treat tuberculosis using a combination of antitubercular substances which will be tested using a novel lung cell model. He holds BSc and MSc in Pharmacy with a successful record of performing pharmaceutical projects in the field of drug delivery.